Greg Shaw Garfield is Director at NeuroPace Inc (NPCE). They have made 1 open-market trade across 1 company since 2021, most recently 2021-04-26.
CIK 0001594406
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $225K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NPCE | 18,891 | $231K |
Shares reported on the most recent Form 4, priced at the 2021-04-26 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NPCE | BUY | 2021-04-21 | 2021-04-23 | $17.00 | $225K | -12.2% | -15.8% | -8.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.